Bulletin – Page 13 – Recovery Research Institute

Hundreds of easy-to-read articles summarizing the latest evidence-based information and findings in addiction treatment and recovery research.

LEARN ABOUT THE RECOVERY BULLETIN STAFF

Suboxone versus Vivitrol

Dec 5, 2017

Suboxone vs. Vivitrol: A Head-to-Head Comparison

Read More

Jun 29, 2020

Opioid overdose: An opportune time to link individuals to treatment?

Read More

Mar 23, 2022

12-step experiences among people taking opioid use disorder medications

Read More

May 14, 2024

Can a recovery support app add benefit to medications for opioid use disorder?

Read More

Nov 15, 2024

Mutual-help groups and medications for Opioid Use Disorder: Does attendance lead to greater medication continuance?

Read More

McDermott et al. examined the predictive value of initial response to buprenorphine-naloxone (i.e., Suboxone) treatment for 12-week treatment outcomes among individuals meeting DSM-IV criteria for opioid dependence (with prescription opioids as the primary substance used).

Feb 21, 2017

Predictive Value of Early Abstinence on Medication Assisted Treatment Outcomes: Buprenorphine-Naloxone in Prescription Opioid Users

Read More

RESEARCH ON MEDICAID BENEFITS FOR ADDICTION MEDICATIONS

Feb 23, 2017

Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs

Read More

Mar 22, 2019

Connecting veterans with medication for opioid use disorder: Are we doing better or worse?

Read More

May 24, 2023

Opioid use disorder medications more likely received in outpatient than residential treatment patients, but helpful for both

Read More

Loading...